| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9343(97)00079-X |
| P698 | PubMed publication ID | 10868141 |
| P2093 | author name string | Goodrich J | |
| P2860 | cites work | Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation | Q34549241 |
| Adenoviruses in the immunocompromised host | Q35231548 | ||
| Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen | Q37265499 | ||
| Prophylaxis and treatment of influenza | Q38139920 | ||
| Parainfluenza Type 3 in a Transplant Unit | Q40190690 | ||
| Strategies for the prevention of cytomegalovirus disease after marrow transplantation | Q40647702 | ||
| Epidemiology of Influenza A virus infection in patients with acute or chronic leukemia | Q40685571 | ||
| Parainfluenza Virus Respiratory Infection after Bone Marrow Transplantation | Q40734883 | ||
| Respiratory syncytial virus infection in immunocompromised adults | Q40784239 | ||
| Infections Due to Herpesviruses in Cardiac Transplant Recipients: Role of the Donor Heart and Immunosuppressive Therapy | Q40835891 | ||
| Influenza immunization of children with neoplastic diseases | Q40862981 | ||
| Cytomegalovirus infection following liver transplantation: review of the literature | Q40947383 | ||
| Parainfluenza virus infection in adult bone marrow transplant recipients | Q44512888 | ||
| Risk factors for survival following combined heart-lung transplantation. The first 100 patients. | Q44734075 | ||
| Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia | Q44937806 | ||
| A Multivariate Analysis of Risk Factors for Cytomegalovirus Infection in Liver-Transplant Recipients | Q44944424 | ||
| A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection | Q45148150 | ||
| Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants | Q45163630 | ||
| Community respiratory virus infections among hospitalized adult bone marrow transplant recipients | Q45769491 | ||
| An outbreak of respiratory syncytial virus in a bone marrow transplant center | Q45866494 | ||
| Influenza immunization of adult patients with malignant diseases | Q50948355 | ||
| Adenovirus infections in patients undergoing bone-marrow transplantation. | Q51198003 | ||
| Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. | Q51663231 | ||
| Antibody response to influenza immunization in adult patients with malignant disease | Q66956827 | ||
| Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones | Q67518698 | ||
| Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia | Q68469036 | ||
| Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors | Q68860207 | ||
| Nonbacterial nonfungal interstitial pneumonitis following autologous bone marrow transplantation in children treated with high-dose chemotherapy without total-body irradiation | Q69823948 | ||
| Interstitial pneumonitis following autologous bone marrow transplantation | Q69832472 | ||
| Interstitial pneumonitis following autologous bone marrow transplantation | Q70155781 | ||
| Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy | Q70461480 | ||
| Influenza A in immunocompromised patients | Q70482204 | ||
| OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation | Q72133269 | ||
| Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy | Q72770789 | ||
| Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis | Q72948444 | ||
| P433 | issue | 3A | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 37-41; discussion 42-3 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | A comparison of cytomegalovirus and community respiratory viruses in immunocompromised patients | |
| P478 | volume | 102 |
Search more.